Su-Hyeon K.
- Country
- Germany
- Department
- Klinik für Hämatologie, Onkologie und Palliativmedizin
Research Overview
Data & Insights
Has run more than one trial at 27 of 192 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of acute myeloid leukemia (AML), with particular emphasis on novel therapeutic approaches for patients who cannot receive intensive chemotherapy treatments.
- Blood Cancer Management
- Targeted Therapy Development
- Combination Treatment Strategies
Research focus includes investigating innovative treatment combinations for patients with specific genetic mutations, particularly those affecting the NPM1 gene in AML.
Personalized Medicine
Expertise centers on developing mutation-specific treatment approaches in hematologic malignancies, tailoring therapeutic strategies based on individual genetic profiles.
- Genetic Mutation Analysis
- Biomarker-Driven Therapy
- Treatment Optimization
The investigator's work emphasizes identifying effective treatments for specific patient populations based on molecular characteristics.
Alternative Treatment Pathways
Focus on developing non-intensive treatment options for patients who are unable to undergo conventional chemotherapy regimens.
- Novel Drug Combinations
- Treatment Safety Profiles
- Quality of Life Considerations
Research interests include exploring therapeutic alternatives that maintain efficacy while considering patient tolerability.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.